Crown, John, Alex J. Eustace, Denis M. Collins, Maccon Keane, Linda Coate, John Kennedy, Seamus O’Reilly, et al. “TCHL – a Phase II Neo-Adjuvant Study Assessing TCH (docetaxel, Carboplatin and Trastuzumab) and TCHL (docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients: A 5-Year Follow-up With Serum Biomarker Analysis”. Acta Oncologica 64 (June 5, 2025): 751–760. Accessed May 27, 2026. https://medicaljournalssweden.se/actaoncologica/article/view/43143.